Perspectives:

• Key Updates from Recent Research Conferences: Structured Treatment Interruption, Intermittent Treatment Strategies, and New Drugs in Development
  Constance A. Benson, MD
• Science and Treatment of HIV and Hepatitis C Virus Coinfection
  Stuart C. Ray, MD
  

Original Contribution:

• Curtailing the HIV Epidemic: The Power of Prevention
  Michael H. Merson, MD
  

Special Contribution:

• Update on Drug Resistance Mutations in HIV-1
  International AIDS Society–USA Drug Resistance Mutations Group
  
  
  

Correction: In "Update on Drug Resistance Mutations in HIV-1" in the December 2001 issue (2001;9[6]:21-23), Robert M. Grant, MD, MPH, of the Gladstone Institute of Virology and Immunology in San Francisco, California, should have been included in the list of members of the Drug Resistance Mutations Group.

Perspectives:

• Prescription Opioid Abuse and Potential Role of Office-Based Opioid Maintenance Treatment in Integrating Medical and Substance Abuse Care
  Patrick G. O'Connor, MD, MPH
• Role of the Provider in Prevention of HIV Infection and Elimination of Tuberculosis and Syphilis
  Michael P. Johnson, MD, MPH
• The HIV Pandemic: Worldwide Perspective and Focus on the United States
  Harold W. Jaffe, MD
  

Special Contribution:

• Questions to and Answers from the IAS–USA Antiretroviral Guidelines Panel
  

Telling Stories:

• Epidemic Beginnings
  Douglas T. Dieterich, MD, FACP
  
  
  

Perspectives:

• Evolving Approaches to Initial Antiretroviral Therapy: When to Start and With What
  Roy M. Gulick, MD, MPH
• Drug Resistance Testing in the Management of Antiretroviral Therapy
  Daniel R. Kuritzkes, MD
• Metabolic Complications of Antiretroviral Therapy: Coronary Artery Disease Risks
  Marshall J. Glesby, MD, PHD
  

Telling Stories:

Perspectives:

• Update on HIV Pharmacology and Therapeutic Drug Monitoring
  Charles W. Flexner, MD
• Metabolic Complications in HIV Disease: Lactemia and Bone Disease
  Henry Masur, MD
• Approaches to HIV Prevention Among Seropositive Patients in the Clinical Care Setting
  Frederick M. Hecht, MD
• Heterogeneity and Public Health in the Global HIV/AIDS Epidemic
  Kevin M. De Cock, MD
  
  
  

In the June 2001 Issue (Volume 9, Issue 2):

Highlights of the 8th Conference on Retroviruses and Opportunistic Infections, Part 2:

• HIV Pathogenesis and Prospects for Vaccine Development
  by Bruce D. Walker, MD
• From Talk to Action in Fighting AIDS in Developing Countries
  by Jeffrey D. Sachs, PhD
  

Perspectives:

• Pathogenesis and Treatment of HIV-Associated Nephropathy
  Paul E. Klotman, MD
• Social, Cultural, and Epidemiologic Considerations in HIV Disease Management in US Latino Populations
  Felix F. Carpio, MD, MPH
  

Special Contributions:

• Update on Drug Resistance Mutations in HIV-1
  by the International AIDS Society–USA Resistance Mutations Project Panel
• Consensus Statement on Antiretroviral Treatment for AIDS in Poor Countries
  by Individual Members of the Faculty of Harvard University
  
  
  

In the March 2001 Issue (Volume 9, Issue 1):

Highlights of the 8th Conference on Retroviruses and Opportunistic Infections:

• Highlights of Basic Science Research
  by Mario Stevenson, PhD
• Complications of HIV Infection and Its Therapies
  by Judith S. Currier, MD, and Diane V. Havlir, MD
• Management of Antiretroviral Therapy
  by Mary A. Albrecht, MD, Eoin P. G. Coakley, MD, Roger T. Inouye, MD, and Scott M. Hammer, MD